Corteva posts smaller quarterly loss
Israel’s Teva Lifts Outlook With War Not Curbing Drug Production
Novartis Spinoff Sandoz to Start Trading as Standalone Drugmaker
US judge overturns Eli Lilly's $176.5 million loss in Teva patent case
Teva to pay $225 million fine and divest cholesterol drug to settle price-fixing charges
Berlusconi Office Backing $100 Million Pharma Startup Qualifyze
Gilead Recovers as Quarterly Revenue Reassures Investors
Corteva profit beats expectations on higher seed prices
Teva agrees to pay $126 million to US hospitals over opioids
Private Equity Backers of Plan B Morning-After Pill Weigh $4 Billion Sale of Company
Roivant Attracts Interest for $7 Billion-Plus Bowel Drug
Teva Weighs Sale of $2 Billion Active Ingredients Unit
«
‹
1
2
›
»
